Breast Health Center
Quality of Care
Caring is in our nature — and we strive for the highest marks when it comes to integrated patient-centered care. And because we emphasize screening and early detection — when breast cancer is most treatable — 84 percent of all breast cancers diagnosed at the Breast Health Center in 2011 were discovered at an early stage, ahead of the national average of 81 percent.
We are fully accredited by the National Accreditation Program for Breast Centers (NAPBC) and our breast cancer quality-focused measures have been endorsed by the National Quality Forum (NQF).
What NAPBC Accreditation Means
We are proud to be fully accredited by the National Accreditation Program for Breast Centers, which means:
- We are fully qualified to offer the full spectrum of interdisciplinary care to patients with breast disease
- Our patients are afforded the most currently available forms of evaluation, treatment and follow-up care
- We have passed a rigorous evaluation by independent clinical surveyors, who recently granted us reaccreditation through 2015
American College of Radiology
Our imaging services are accredited by the American College of Radiology (ACR), and we were designated a Breast Imaging Center of Excellence in 2010.
National Quality Measures for Breast Centers™
We also participate in the National Quality Measures for Breast Centers™ Program (NQMBC) to track and measure quality performance in more than 30 separate quality indicators.
Read more about our accreditations and commitment to quality here.
Breast Cancer Quality Measures
The following three breast cancer quality-focused measures have been endorsed by the National Quality Forum (NQF). With submission of EMHC-specific data to the National Cancer Data Base (NCDB), we are able to compare our compliance rate of these accountability measures against state and national rates. These measures emphasize not only the quality of patient care but also the importance of accurate and complete documentation.
Comparison data below are for breast cancer cases diagnosed in calendar year 2011.
Breast Conservation Surgery/Radiation Therapy
Radiation therapy is administered within one year (365 days) of diagnosis for women under age 70 receiving breast-conserving surgery for breast cancer.
Combination chemotherapy is considered or administered within four months (120 days) of diagnosis for women under 70 with AJCC T1c N0 M0, or Stage II or III ERA and PRA negative breast cancer.
Tamoxifen, a third-generation aromatase inhibitor, is considered or administered within one year (365 days) of diagnosis for women with AJCC T1c N0 M0, or Stage II or III ERA and/or PRA positive breast cancer.
Source: American College of Surgeons Commission on Cancer (CoC), National Cancer Data Base (NCDB), Cancer Program Practice Profile Report (CP3R) — 10/02/2013
EMHC: Elmhurst Memorial Healthcare
IL: All CoC-Accredited Cancer Programs in the State of Illinois
CCCP: All CoC-Accredited Comprehensive Community Cancer Programs (EMHC is a CCCP program.)